Our Blog Melanoma360

Featured image for “Early Clinical Trial Shows Drug Activity to Work in Patients with Acral and Mucosal Melanoma”
06/05/2025

Early Clinical Trial Shows Drug Activity to Work in Patients with Acral and Mucosal Melanoma

Results of a Phase 1/2 clinical trial showed promising data for patients with advanced acral and mucosal melanoma. The results…
Blog - Melanoma360
Melanoma Research
Featured image for “Results Prove Immunotherapy Should be the Initial Treatment for BRAF Mutant Tumors”
06/05/2025

Results Prove Immunotherapy Should be the Initial Treatment for BRAF Mutant Tumors

Five-year clinical trial results presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago confirmed…
Blog - Melanoma360
Melanoma Research
Featured image for “Trial Result Confirms the Advantage of Cemiplimab for Skin Cancer at High Risk of Recurrence”
06/03/2025

Trial Result Confirms the Advantage of Cemiplimab for Skin Cancer at High Risk of Recurrence

We usually don’t feature nonmelanoma skin cancer articles here, but we thought you might be interested in what’s happening in…
Blog - Melanoma360
Melanoma Research
Featured image for “Halozyme Announces Bristol Myers Squibb Received European Commission Approval for Subcutaneous Opdivo® (nivolumab) Co-Formulated with ENHANZE® Across Multiple Solid Tumor Indications”
05/28/2025

Halozyme Announces Bristol Myers Squibb Received European Commission Approval for Subcutaneous Opdivo® (nivolumab) Co-Formulated with ENHANZE® Across Multiple Solid Tumor Indications

News provided byHalozyme Therapeutics, Inc. May 28, 2025, 08:30 ET Opdivo® is the first and only PD-1 inhibitor approved for subcutaneous (SC)…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “Parenting Through Cancer”
05/14/2025

Parenting Through Cancer

In this deeply personal episode, Drs. Samantha and Samuel Siegel share their journey of navigating cancer, medical school, and family…
Blog - Melanoma360
Podcast
Featured image for “Tri-State Melanoma Consortium – Inaugural Convening”
05/09/2025

Tri-State Melanoma Consortium – Inaugural Convening

Last night, leading melanoma researchers and clinicians from across the New York , New Jersey, and Connecticut region gathered at…
Blog - Melanoma360
Melanoma Research
Featured image for “AIM at Melanoma + WEARSPF®: Partnering for a Cause This Melanoma Awareness Month”
05/01/2025

AIM at Melanoma + WEARSPF®: Partnering for a Cause This Melanoma Awareness Month

May is Melanoma Awareness Month—a time to come together, raise awareness, and take meaningful steps toward ending one of the…
Blog - Melanoma360
Philanthropy
Featured image for “Hope, Purpose, and Progress: Melanoma Awareness Month with AIM”
05/01/2025

Hope, Purpose, and Progress: Melanoma Awareness Month with AIM

Dear Friend, May is Melanoma Awareness Month, a time to honor the progress made in the fight against this deadly…
Blog - Melanoma360
President's Letter
Featured image for “Your Style Can Save Lives – Lilly Pulitzer Giving Day is Here!”
04/28/2025

Your Style Can Save Lives – Lilly Pulitzer Giving Day is Here!

Mark your calendar—May 2nd is a day to shop for a cause! We’re thrilled to announce that AIM at Melanoma…
Blog - Melanoma360
Philanthropy
Featured image for “From Diagnosis to Crown: Miss Pennsylvania’s Journey of Advocacy and Awareness”
04/28/2025

From Diagnosis to Crown: Miss Pennsylvania’s Journey of Advocacy and Awareness

By Mara Klecker Page Weinstein has a special request for photographers who take her portraits: Don’t edit out the scar…
Blog - Melanoma360
Survivor Stories
06/05/2025

Early Clinical Trial Shows Drug Activity to Work in Patients with Acral and Mucosal Melanoma

Results of a Phase 1/2 clinical trial showed promising data for patients with advanced acral and mucosal melanoma. The results…
Featured image for “Early Clinical Trial Shows Drug Activity to Work in Patients with Acral and Mucosal Melanoma”
Blog - Melanoma360
 | 
Melanoma Research
06/05/2025

Results Prove Immunotherapy Should be the Initial Treatment for BRAF Mutant Tumors

Five-year clinical trial results presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago confirmed…
Featured image for “Results Prove Immunotherapy Should be the Initial Treatment for BRAF Mutant Tumors”
Blog - Melanoma360
 | 
Melanoma Research
06/03/2025

Trial Result Confirms the Advantage of Cemiplimab for Skin Cancer at High Risk of Recurrence

We usually don’t feature nonmelanoma skin cancer articles here, but we thought you might be interested in what’s happening in…
Featured image for “Trial Result Confirms the Advantage of Cemiplimab for Skin Cancer at High Risk of Recurrence”
Blog - Melanoma360
 | 
Melanoma Research
05/28/2025

Halozyme Announces Bristol Myers Squibb Received European Commission Approval for Subcutaneous Opdivo® (nivolumab) Co-Formulated with ENHANZE® Across Multiple Solid Tumor Indications

News provided byHalozyme Therapeutics, Inc. May 28, 2025, 08:30 ET Opdivo® is the first and only PD-1 inhibitor approved for subcutaneous (SC)…
Featured image for “Halozyme Announces Bristol Myers Squibb Received European Commission Approval for Subcutaneous Opdivo® (nivolumab) Co-Formulated with ENHANZE® Across Multiple Solid Tumor Indications”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
05/14/2025

Parenting Through Cancer

In this deeply personal episode, Drs. Samantha and Samuel Siegel share their journey of navigating cancer, medical school, and family…
Featured image for “Parenting Through Cancer”
Blog - Melanoma360
 | 
Podcast
05/09/2025

Tri-State Melanoma Consortium – Inaugural Convening

Last night, leading melanoma researchers and clinicians from across the New York , New Jersey, and Connecticut region gathered at…
Featured image for “Tri-State Melanoma Consortium – Inaugural Convening”
Blog - Melanoma360
 | 
Melanoma Research
05/01/2025

AIM at Melanoma + WEARSPF®: Partnering for a Cause This Melanoma Awareness Month

May is Melanoma Awareness Month—a time to come together, raise awareness, and take meaningful steps toward ending one of the…
Featured image for “AIM at Melanoma + WEARSPF®: Partnering for a Cause This Melanoma Awareness Month”
Blog - Melanoma360
 | 
Philanthropy
05/01/2025

Hope, Purpose, and Progress: Melanoma Awareness Month with AIM

Dear Friend, May is Melanoma Awareness Month, a time to honor the progress made in the fight against this deadly…
Featured image for “Hope, Purpose, and Progress: Melanoma Awareness Month with AIM”
Blog - Melanoma360
 | 
President's Letter
04/28/2025

Your Style Can Save Lives – Lilly Pulitzer Giving Day is Here!

Mark your calendar—May 2nd is a day to shop for a cause! We’re thrilled to announce that AIM at Melanoma…
Featured image for “Your Style Can Save Lives – Lilly Pulitzer Giving Day is Here!”
Blog - Melanoma360
 | 
Philanthropy
04/28/2025

From Diagnosis to Crown: Miss Pennsylvania’s Journey of Advocacy and Awareness

By Mara Klecker Page Weinstein has a special request for photographers who take her portraits: Don’t edit out the scar…
Featured image for “From Diagnosis to Crown: Miss Pennsylvania’s Journey of Advocacy and Awareness”
Blog - Melanoma360
 | 
Survivor Stories